NPI registry status
Active
2026 NPPES data Pharmacist NPI 1154677144 PHARMD
Verify on CMS → Julie Oda, PHARMD
Pharmacist in San Diego, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 291,043 in Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
697
Medicare Part D claims · 294 beneficiaries · Pharmacist avg: 135
Generic prescribing
67%
generic claims · 30% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Julie Oda, PHARMD filed 697 Medicare Part D claims in 2023 as a Pharmacist in San Diego, California, prescribing 67% generic.
- 697
- Part D claims, 2023
- 67%
- generic prescribing
- ≥69th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1154677144 · Pharmacist
NPI-10 · ENUM-MID · TAX-MEGA · RX-LIGHT · BOOK-MID · PHOTO-ENUM
- NPI-10 1154677144
- ENUM-MID 2012
- TAX-MEGA 291K Pharmacist
- RX-LIGHT 697
- BOOK-MID 32,376 in California
- PHOTO-ENUM Erika Romeus · 2012
Julie Oda, PHARMD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
697 ≥ 69th percentile 69% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about Julie Oda, PHARMD?
Quality data not reportedPrimary specialty
Pharmacist
Medicare Part D claims
697 5× vs specialty avg
Specialty distribution in California
How Pharmacist compares to other specialties among California providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pharmacist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1154677144 |
|---|---|
| Specialty | Pharmacist |
| Credentials | PHARMD |
| Gender | Female |
| NPI Issued | 07/27/2012 |
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Julie Oda, PHARMD. To verify Julie Oda, PHARMD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Julie Oda, PHARMD - brand share 30.0%
Pharmacist average
30% brand-name claims vs 67% generic, on 697 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
697
Total Claims
$68K
Total Drug Cost
294
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,069
- Total Day Supply
- 62,061
- Brand vs Generic
- 30% brand / 67% generic
- Brand Drug Cost
- $60K
- Generic Drug Cost
- $8K
Patient Demographics
- Average Patient Age
- 71.7 years
- Avg HCC Risk Score
- 1.20
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 19, 65-74: 193, 75-84: 69, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Julie Oda, PHARMD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Glipizide
Glipizide
77 claims
- Amlodipine Besylate
Amlodipine Besylate
63 claims
- Humulin N Kwikpen
Humulin N Kwikpen
60 claims
- Metformin Hcl
Metformin Hcl
56 claims
- Losartan Potassium
Losartan Potassium
39 claims
- Bisoprolol Fumarate
Bisoprolol Fumarate
35 claims
- Lisinopril
Lisinopril
34 claims
- Humulin N
Humulin N
33 claims
| Drug | Claims |
|---|---|
| Glipizide | 77 |
| Amlodipine Besylate | 63 |
| Humulin N Kwikpen Insulin Nph Human Isophane | 60 |
| Metformin Hcl | 56 |
| Losartan Potassium | 39 |
| Bisoprolol Fumarate | 35 |
| Lisinopril | 34 |
| Humulin N Insulin Nph Human Isophane | 33 |
| Hydrochlorothiazide | 24 |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pharmacist Overview
How Julie Oda, PHARMD fits within the Pharmacist landscape nationally.
291,043
Pharmacist Providers in US
56
States with Pharmacist
135
Avg Claims per Provider
Julie Oda, PHARMD's 697 claims are above the specialty average of 135.
Nationwide Pharmacist peers with similar MIPS or enrollment year
Two federal-record peer sets for Oda, both outside California so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2012)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pharmacist Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Oda.
One of 32,376 Pharmacist providers enrolled in California, 5 are shown here.
Dr. Caroline A-Haja
PHARM.D.
San Pedro, CA
Gayatri Aachi
Livermore, CA
Dr. Mahshid Aalam
PHARMD
Los Angeles, CA
Jaleh Aaliiveli
San Ramon, CA
Dr. Cassi Aarvig
RPH
Tracy, CA
Compare Pharmacist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Julie Oda, PHARMD's specialty? ▼
Julie Oda, PHARMD specializes in Pharmacist and practices in San Diego, California. Credentials: PHARMD.
How much does Julie Oda, PHARMD prescribe under Medicare Part D? ▼
In 2023, Julie Oda, PHARMD wrote 697 Medicare Part D claims totaling $68K in drug costs for 294 beneficiaries.
Where is Julie Oda, PHARMD located? ▼
Julie Oda, PHARMD is located at 3350 LA JOLLA VILLAGE DR, San Diego, CA, 92161. Phone: (858) 642-6465.
What is Julie Oda, PHARMD's NPI number? ▼
Julie Oda, PHARMD's National Provider Identifier (NPI) is 1154677144, issued on 07/27/2012.
Does Julie Oda, PHARMD prescribe more brand-name or generic drugs? ▼
Julie Oda, PHARMD's prescribing is 30% brand-name and 67% generic drugs by claim count, with $60K in brand drug costs.
How many Pharmacist providers are there in the US? ▼
There are 291,043 Pharmacist providers across 56 states in the US. The average Pharmacist provider writes 135 Medicare Part D claims per year.
What drugs does Julie Oda, PHARMD prescribe most often? ▼
Based on 2023 Medicare Part D data, Julie Oda, PHARMD's most frequently prescribed drugs include Glipizide, Amlodipine Besylate, Humulin N Kwikpen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Julie Oda, PHARMD accept Medicare? ▼
Julie Oda, PHARMD appears in CMS Medicare data with 697 Part D claims and 294 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Julie Oda, PHARMD's credentials? ▼
Julie Oda, PHARMD's NPI is 1154677144 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.